These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14028342)

  • 1. [On the pathogenesis of hemolytic disease of newborn].
    DOERDELMANN P
    Z Geburtshilfe Gynakol; 1962 Dec; 160():19-49. PubMed ID: 14028342
    [No Abstract]   [Full Text] [Related]  

  • 2. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histological study of the liver using needle biopsy in hemolytic disease of the newborn caused by materno-fetal blood incompatibility].
    ALBEGGIANI A; PUCCI E
    Pediatria (Napoli); 1962; 70():863-910. PubMed ID: 14011698
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of the kinetic characteristics of red blood cell acetylcholinesterase in ABO, Rh hemolytic disease of the newborn and thalassemia major cases.
    Ozand P; Artvinli S; Yarimağan S
    Turk J Pediatr; 1970; 12(1):1-7. PubMed ID: 4992911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
    Salvioli GP; Allocca G; Ambrosioni G
    Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphological and some histo- and biochemical changes in the heart during fetal and neonatal hemolytic disease].
    Volchenko KL
    Vopr Okhr Materin Det; 1970 Oct; 15(10):15-21. PubMed ID: 4995466
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
    Lindo-Haynes G
    Med Lab Sci; 1980 Jun; 37(3):263-6. PubMed ID: 6783806
    [No Abstract]   [Full Text] [Related]  

  • 9. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemia in hemolytic disease of the newborn].
    Leopardi F; D'Avanzo M
    Pediatria (Napoli); 1970; 78(1):63-74. PubMed ID: 4987178
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ABO incompatibility on Rh isoimmunization.
    KELLY WL; JACOBS WM
    Obstet Gynecol; 1963 May; 21():587-92. PubMed ID: 14031839
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE DEVELOPMENT OF THROMBOCYTE COUNT FOLLOWING EXCHANGE TRANSFUSION IN INFANCY].
    DUX E; KOVACS Z; PATAKI L
    Orv Hetil; 1963 Sep; 104():1641-5. PubMed ID: 14054562
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Considerations on the treatment of hemolytic disease of the newborn, particularly on the utilization of Rh positive blood in exchange transfusions].
    HUBINONT PO; MASSART-GUIOT T
    Brux Med; 1955 May; 35(19):934-53; contd. PubMed ID: 14378711
    [No Abstract]   [Full Text] [Related]  

  • 15. Considerations on the treatment of hemolytic disease of the newborn with special reference to the use of Rh-positive blood in exchange transfusion.
    HUBINONT PO; MASSART-GUIOT T
    Brux Med; 1955 May; 35(20):994-9. PubMed ID: 14378714
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histological peculiarities of the placenta in materno-fetal isoimmunization due to Rh factors].
    Capone N; Urbanetti S; Sobrino R; Sobrino S
    Minerva Ginecol; 1982 Mar; 34(3):151-4. PubMed ID: 6806722
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of Rh factor isoimmunization in a 1st pregnancy with appearance of hemolytic disease in the newborn].
    ANTUZZI P; ROSSI G
    Fracastoro; 1962; 55():394-9. PubMed ID: 14013406
    [No Abstract]   [Full Text] [Related]  

  • 18. The rare factor, Rh variant: a case report of hemolytic disease of the newborn infant due to D-u factor incompatibility.
    HARA S; CRUMP EP
    Int Rec Med; 1961 Jun; 174():349-51. PubMed ID: 13711404
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maternal iso-immunization and hemolytic disease of the newborn].
    GOIRAND R; MARTIN-LAVAL J
    Fr Med; 1953 Aug; 16(8):12-21. PubMed ID: 13107838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.